Literature DB >> 30043292

Antibiotic susceptibility of Staphylococcus aureus isolated from subclinical bovine mastitis cases and in vitro efficacy of bacteriophage.

Diego F Varela-Ortiz1, José E Barboza-Corona2,3, Joaquín González-Marrero4, Ma Fabiola León-Galván2,3, Mauricio Valencia-Posadas2,5, Alma A Lechuga-Arana6, Cynthia G Sánchez-Felipe7, Fernanda Ledezma-García7, Abner J Gutiérrez-Chávez8,9.   

Abstract

Staphylococcus aureus is an opportunistic pathogen that may cause severe infections in livestock, and represents the major cause of mastitis in dairy cows. Currently, instead of using antibiotics, new strategies are sought to reduce this clinical health problem. The aim of this study was to determine the efficacy of phage therapy to kill S. aureus strains obtained from farms located at the State of Guanajuato, México. Thirty-six S. aureus strains from cow milk with subclinical mastitis were isolated and identified, and the susceptibility to antibiotics and four phages also isolated in this work was tested. It was found that more of 90% of S. aureus isolates were not susceptible to six or more antibiotics, and 100% were resistant to penicillin, dicloxacillin, cefotaxime, ampicillin and cephalothin, and 81 and 77%, to tetracycline and cefuroxime, respectively. Fortunately, 100% of S. aureus isolates were susceptible to phages used in this work, which was detected as clear zones using specific phage. It was shown for the first time, that phages used in this study are active against pathogenic S. aureus and might be incorporated into the therapy as an important tool for the control of staphylococcal bovine mastitis, specially to antibiotic-resistant S. aureus strains isolated in farm located at the state of Guanajuato, México; and its use might be extended to other regions inside or outside the country.

Entities:  

Keywords:  Bacteriophage; Bovine mastitis; Multi-resistance pattern; Spot test; Staphylococcus aureus

Mesh:

Substances:

Year:  2018        PMID: 30043292     DOI: 10.1007/s11259-018-9730-4

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  32 in total

1.  Experiments and observations leading to development of the California mastitis test.

Authors:  O W SCHALM; D O NOORLANDER
Journal:  J Am Vet Med Assoc       Date:  1957-03-01       Impact factor: 1.936

2.  Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.

Authors:  Mathias Schmelcher; Anne M Powell; Stephen C Becker; Mary J Camp; David M Donovan
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

Review 3.  Genetics of antimicrobial resistance in Staphylococcus aureus.

Authors:  Slade O Jensen; Bruce R Lyon
Journal:  Future Microbiol       Date:  2009-06       Impact factor: 3.165

4.  Reliability in somatic cell count measurement of clinical mastitis milk using DeLaval cell counter.

Authors:  Kazuhiro Kawai; Tomohito Hayashi; Yoshio Kiku; Tomoyuki Chiba; Hajime Nagahata; Hidetoshi Higuchi; Tetsu Obayashi; Seigo Itoh; Ken Onda; Sachiko Arai; Reiichiro Sato; Toshio Oshida
Journal:  Anim Sci J       Date:  2013-10-15       Impact factor: 1.749

5.  The use of bacteriophages in eliminating polyresistant strains of Staphylococcus aureus and Streptococcus agalactiae.

Authors:  Z Brnáková; J Farkasovská; A Godány
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

Review 6.  Management and treatment of staphylococcal mastitis.

Authors:  Philip M Sears; Kate K McCarthy
Journal:  Vet Clin North Am Food Anim Pract       Date:  2003-03       Impact factor: 3.357

Review 7.  Economic effects of bovine mastitis and mastitis management: a review.

Authors:  T Halasa; K Huijps; O Østerås; H Hogeveen
Journal:  Vet Q       Date:  2007-03       Impact factor: 3.320

8.  Population structure and antimicrobial profile of Staphylococcus aureus strains associated with bovine mastitis in China.

Authors:  Lili Zhang; Yuchen Li; Hongduo Bao; Ruicheng Wei; Yan Zhou; Hui Zhang; Ran Wang
Journal:  Microb Pathog       Date:  2016-06-02       Impact factor: 3.738

9.  Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study.

Authors:  Laura García-Álvarez; Matthew T G Holden; Heather Lindsay; Cerian R Webb; Derek F J Brown; Martin D Curran; Enid Walpole; Karen Brooks; Derek J Pickard; Christopher Teale; Julian Parkhill; Stephen D Bentley; Giles F Edwards; E Kirsty Girvan; Angela M Kearns; Bruno Pichon; Robert L R Hill; Anders Rhod Larsen; Robert L Skov; Sharon J Peacock; Duncan J Maskell; Mark A Holmes
Journal:  Lancet Infect Dis       Date:  2011-08       Impact factor: 25.071

10.  Molecular detection and sensitivity to antibiotics and bacteriocins of pathogens isolated from bovine mastitis in family dairy herds of central Mexico.

Authors:  Ma Fabiola León-Galván; José E Barboza-Corona; A Arianna Lechuga-Arana; Mauricio Valencia-Posadas; Daniel D Aguayo; Carlos Cedillo-Pelaez; Erika A Martínez-Ortega; Abner J Gutierrez-Chavez
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

View more
  2 in total

1.  Prevalence, Antimicrobial Resistance, and Characterization of Staphylococcus aureus Isolated from Subclinical Bovine Mastitis in East Coast Malaysia.

Authors:  Shamsaldeen Ibrahim Saeed; Khairun Anisa Mat Yazid; Hidayatul Athirah Hashimy; Siti Khadijah Dzulkifli; Fatihah Nordin; Nik Azmi Nik Him; Mohd Fikry Fahmi Bin Omar; Erkihun Aklilu; Maizan Mohamad; Che Wan Salma Zalati; Nor Fadhilah Kamaruzzaman
Journal:  Animals (Basel)       Date:  2022-06-29       Impact factor: 3.231

Review 2.  Advances in therapeutic and managemental approaches of bovine mastitis: a comprehensive review.

Authors:  Khan Sharun; Kuldeep Dhama; Ruchi Tiwari; Mudasir Bashir Gugjoo; Mohd Iqbal Yatoo; Shailesh Kumar Patel; Mamta Pathak; Kumaragurubaran Karthik; Sandip Kumar Khurana; Rahul Singh; Bhavani Puvvala; Rajendra Singh; Karam Pal Singh; Wanpen Chaicumpa
Journal:  Vet Q       Date:  2021-12       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.